Multivariate analysis including SASH3 expression, number of lymph nodes, tumor size, and AJCC stage (all p < 0.2) showed that SASH3 expression and number of lymph nodes were significantly associated with prognosis of invasive BRCA patients (p < 0.05, Table 3). This evidence concerns the gene SASH3 and neoplasm.